Previous close | 2.8500 |
Open | 2.8400 |
Bid | 2.9100 x 800 |
Ask | 2.9400 x 800 |
Day's range | 2.7800 - 2.9575 |
52-week range | 0.8010 - 9.6200 |
Volume | |
Avg. volume | 2,217,498 |
Market cap | 356.631M |
Beta (5Y monthly) | 1.51 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Curis (CRIS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript February 28, 2024 Mersana Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Mersana Therapeutics Fourth Quarter 2023 Conference Call and Webcast. Currently, all […]
Key Insights Mersana Therapeutics' estimated fair value is US$6.60 based on 2 Stage Free Cash Flow to Equity Mersana...